The State of New Jersey Marijuana Legalization


Ryan Allway

July 9th, 2019

Policy, State Marijuana Laws


New Jersey and river Hudson

New Jersey has nearly 50,000 medical marijuana patients and out-of-state patients may legally bring their marijuana into the state for up to six months. With nearly nine million residents, the state is the 11th largest in the United States and the most densely populated state with more than 1,200 people per square mile, making it a leading cannabis market.

Let’s take a look at the state’s recreational and medical marijuana programs.

Recreational Marijuana Set for 2020

New Jersey decided to pause its efforts to legalize recreational cannabis in May 2019 after failing to secure enough votes in the Senate to pass the bill — a move that spurred a similar move in New York. Lawmakers instead plan to put the measure to vote during the 2020 general election in a move that would mirror that of many other states.

Illinois is one of the few states that passed cannabis legalization through legislative means rather than a ballot measure. New York and New Jersey hoped to do the same but could not reach a consensus on the bills. The 2020 ballot initiative would involve voters actively instructing lawmakers to pass cannabis legalization measures.

During the 2019 session, lawmakers still plan to move forward with bills designed to expand its medical cannabis program and expunge existing marijuana convictions. These social justice and medical initiatives could pave the way for recreational legalization by establishing the Cannabis Regulatory Commission, which will ultimately regulate both markets.

Improved Medical Marijuana Program

New Jersey has made a medical marijuana program in place for the past ten years, but the passage of the Jake Honig Compassionate Use Marijuana Act in May 2019 introduced some big changes. Lawmakers believe that the new program could create a ‘national model’ for medical marijuana by introducing major changes to the entire process.

Doctors were the biggest bottleneck with the old regulations. Many doctors fear the the federal government would target them while the drug remains illegal on a federal level. At the same time, the state suspended the license of many prominent medical marijuana doctors in the state, saying that they didn’t maintain a “bona fide” relationships with patients.

The new law will remove the “bona fide” requirement, which means that doctors could recommend medical marijuana on a patient’s first visit, as long as they examine the patient, diagnose the issue and feel confident that medical marijuana would address the underlying issue. Health Commissioner Shereef Elnahal has also campaigned to sign up more doctors.

Where to Find Dispensaries

New Jersey has several medical marijuana dispensaries located near major population centers and more dispensaries are expected to open over the coming months.

In June, the Department of Health announced their intent to license over 100 Alternative Treatment Centers with up to half of the new facilities operating as a dispensary and the others operating as cultivators and manufacturers.

The six existing medical marijuana dispensaries include:

  • Breakwater Alternative Treatment Center (Cranbury)
  • Compassionate Care Foundation (Egg Harbor)
  • Curaleaf NJ (Bellmawr)
  • Garden State Dispensary (Woodbridge)
  • Greenleaf Compassion Center (Montclair)
  • Harmony Dispensary (Secaucus)

Six more dispensaries were approved by the Department of Health last year, but they have been delayed by unsuccessful applicants that are suing in court. The newly created Cannabis Regulatory Commission will also be required to issue permits to at least two more dispensaries located in the northern and southern parts of the stat over the next year.

What’s Next?

New Jersey’s new social media and medical marijuana reforms could make cannabis much more affordable for patients and decriminalize the drug. In 2020, voters will be looking forward to a ballot measure that could finally tip the scales and bring recreational legalization to the state following what’s sure to be a hotly contested general election.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Media Group (CannabisFN), owned and operated by CFN Enterprises Inc. (OTCQB: CNFN), is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading